Search results
Results: 89
Number of items: 89
-
Nogueira, F., van Ham, S. M., & ten Brinke, A. (2025). Extracorporeal Photopheresis in Solid Organ Transplantation: Modulating B-cell Responses to Improve Graft Survival. Transplantation Direct, 11(9), Article e1833. https://doi.org/10.1097/TXD.0000000000001833 -
Keijser, J. B. D., Tas, S. W., Verstegen, N. J. M., ten Brinke, A., van Ham, M. S., T2B! immunity against SARS-CoV-2 study group, & Löwenberg, M. (2025). Evolution of SARS-CoV-2 antibody repertoire after successive mRNA vaccinations under immunosuppressive treatment. eBioMedicine, 113, Article 105620. https://doi.org/10.1016/j.ebiom.2025.105620 -
Valk, A. M., Tas, S. W., van Ham, S. M., ten Brinke, A., & T2B! immunity against SARS-CoV-2 study group (2024). Suppressed IgG4 class switching in dupilumab‐ and TNF inhibitor‐treated patients after mRNA vaccination. Allergy, 79(7), 1952–1961. https://doi.org/10.1111/all.16089 -
Keijzer, S., Oskam, N., Ooijevaar-de Heer, P., Steenhuis, M., Keijser, J. B. D., Wieske, L., van Dam, K. P. J., Stalman, E. W., Kummer, L. Y. L., Boekel, L., Kuijpers, T. W., ten Brinke, A., van Ham, S. M., Eftimov, F., Tas, S. W., Wolbink, G. J., Rispens, T., & T2B! immunity against SARS-CoV-2 study group (2024). Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection. Frontiers in Immunology, 15, Article 1314507. https://doi.org/10.3389/fimmu.2024.1314507 -
Kuijper, L. H., Kreher, C., Elias, G., Claireaux, M., Kerster, G., Bos, A. V., Duurland, M. C., Konijn, V. A. L., Paul, A. G. A., de Jong, N., de Jongh, R., Steenhuis, M., Garcia-Vallejo, J. J., van Gils, M. J., Kuijpers, T. W., Eftimov, F., Rispens, T., van der Schoot, C. E., van Ham, S. M., & ten Brinke, A. (2024). Longevity of antibody responses is associated with distinct antigen-specific B cell subsets early after infection. Frontiers in Immunology, 15, Article 1505719. https://doi.org/10.3389/fimmu.2024.1505719 -
Kummer, L. Y. L., Fernández Blanco, L., Kreher, C., Bos, A., Kuijper, L. H., Verstegen, N. J. M., van de Sandt, C. E., Konijn, V. A. L., Duurland, M. C., Menage, C., Jorritsma, T., Steenhuis, M., Hagen, R. R., van den Dijssel, J., de Jongh, R., Ashhurst, T., van Gils, M. J., Garcia-Vallejo, J. J., Claireaux, M., ... T2B! immunity against SARS-CoV-2 study group (2024). Methotrexate treatment hampers induction of vaccine-specific CD4 T cell responses in patients with IMID. RMD OPEN, 10(4), Article e004664. https://doi.org/10.1136/rmdopen-2024-004664 -
Verstegen, N. J. M., Hagen, R. R., Kreher, C., Kuijper, L. H., Dijssel, J. V. D., Ashhurst, T., Kummer, L. Y. L., Palomares Cabeza, V., Steenhuis, M., Duurland, M. C., Jongh, R. D., Schoot, C. E. V. D., Konijn, V. A. L., Mul, E., Kedzierska, K., van Dam, K. P. J., Stalman, E. W., Boekel, L., Wolbink, G., ... T2B! immunity against SARS-CoV-2 study group (2024). T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination. Journal of Neurology, Neurosurgery and Psychiatry, 95(9), 855–864. https://doi.org/10.1136/jnnp-2023-332224 -
van den Dijssel, J., van Ham, S. M., ten Brinke, A., & T2B! immunity against SARS-CoV-2 study group (2024). mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses. Journal of autoimmunity, 144, Article 103175. https://doi.org/10.1016/j.jaut.2024.103175
Page 2 of 9